Ponz, InesNuche, JorgeSanchez-Sanchez, VioletaSanchez-Gonzalez, JavierBlazquez-Bermejo, ZorbaCaravaca-Perez, PedroGarcia-Cosio-Carmena, Maria Doloresde-Juan-Baguda, Javier SRodríguez-Chaverri, AdrianaSarnago-Cebada, FernandoArribas-Ynsaurriaga, FernandoIbáñez, BorjaDelgado-Jiménez, Juan F2021-08-252021-08-252021-01Hearts. 2021; 2(1):5-142673-3846http://hdl.handle.net/20.500.12105/13307Right heart catheterization remains necessary for the diagnosis of pulmonary hypertension and, therefore, for the prognostic evaluation of patients with chronic heart failure. The non-invaSive Assessment of Pulmonary vasculoPathy in Heart failure (SAPPHIRE) study was designed to assess the feasibility and prognostic relevance of a non-invasive evaluation of the pulmonary artery vasculature in patients with heart failure and pulmonary hypertension. Patients will undergo a right heart catheterization, cardiac resonance imaging, and a pulmonary function test in order to identify structural and functional parameters allowing the identification of combined pre- and postcapillary pulmonary hypertension, and correlate these findings with the hemodynamic dataengVoRhttp://creativecommons.org/licenses/by/4.0/Atribución 4.0 Internacional215-1410.3390/hearts20100022673-3846Heartsopen access